276 related articles for article (PubMed ID: 17216593)
1. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
[TBL] [Abstract][Full Text] [Related]
2. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
Radermecker RP; Renard E; Scheen AJ
Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
[TBL] [Abstract][Full Text] [Related]
3. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
4. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
[TBL] [Abstract][Full Text] [Related]
6. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
[TBL] [Abstract][Full Text] [Related]
7. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
8. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
[TBL] [Abstract][Full Text] [Related]
9. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
Castéra V; Dutour-Meyer A; Koeppel M; Petitjean C; Darmon P
Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
[TBL] [Abstract][Full Text] [Related]
10. Insulin allergy desensitization with simultaneous intravenous insulin and continuous subcutaneous insulin infusion.
Neville KA; Verge CF; Wainstein BK; Woodhead HJ; Ziegler JB; Walker JL
Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):420-2. PubMed ID: 18775000
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin.
Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL
Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615
[No Abstract] [Full Text] [Related]
13. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pańkowska E; Szypowska A; Lipka M; Skórka A
Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
[TBL] [Abstract][Full Text] [Related]
14. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
15. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
Monami M; Lamanna C; Marchionni N; Mannucci E
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with continuous subcutaneous insulin infusion for allergy to human insulin and its analogs.
Zhang L; Zhang M; Liu YY; Hu M; Zhou X; Luo Y
Diabetes Res Clin Pract; 2011 Oct; 94(1):e1-2. PubMed ID: 21742397
[TBL] [Abstract][Full Text] [Related]
18. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?
Cogen FR; Henderson C; Hansen JA; Streisand R
Clin Pediatr (Phila); 2007 Nov; 46(9):777-9. PubMed ID: 17585009
[TBL] [Abstract][Full Text] [Related]
19. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
20. [Insulin treatment in children].
Birkebaek NH; Hertz B; Olsen BS
Ugeskr Laeger; 2009 Jun; 171(23):1919-22. PubMed ID: 19500514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
